These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6045024)

  • 21. [Therapeutic efficiency of ethionamide and prothionamide].
    Kozulitsyna TI; Zemskova ZS
    Probl Tuberk; 1969; 47(8):66-9. PubMed ID: 5375685
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study on the antituberculous activity of Tuberactin, a new antibiotic].
    Toyohara M
    Kekkaku; 1968 Jul; 43(7):245-8. PubMed ID: 5727835
    [No Abstract]   [Full Text] [Related]  

  • 23. [Glucose-6-phosphatase activity in tuberculosis-infected animals during long-term use of bacteriostatic agents and group B vitamins].
    Romaniuk SL
    Probl Tuberk; 1971; 49(1):76-9. PubMed ID: 4325146
    [No Abstract]   [Full Text] [Related]  

  • 24. Antituberculous effect of histamine.
    Kader MM; Shoub A; El-Moursi BA; Halawa F
    Kekkaku; 1979 Aug; 54(8):419-21. PubMed ID: 537303
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of sodium nucleinate on the development of morphologic reactions during antibacterial therapy of experimental tuberculosis].
    Baranova TV
    Probl Tuberk; 1986; (12):46-50. PubMed ID: 3823082
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in the fibronectin level of the blood and bronchoalveolar lavage fluid in experimental tuberculosis in guinea pigs].
    Kaminskaia GO; Grigor'eva EV; Gedymin LE; Sivakov AE
    Probl Tuberk; 1993; (1):50-4. PubMed ID: 8327442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An experimental intermittent method of treating tuberculosis].
    Shlapak PT; Belinskiĭ AN
    Probl Tuberk; 1971; 49(12):75-7. PubMed ID: 5159695
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experimental and clinical aspects of the treatment of tuberculosis with Pasiniazide (p-aminosalicylate of isoniazid)].
    Wernsdorfer G; Wernsdorfer WH
    Maroc Med; 1968 Dec; 48(519):721-4. PubMed ID: 5757743
    [No Abstract]   [Full Text] [Related]  

  • 29. [On the therapeutic effect of 4,4'diisoamyloxythiocarbanilid (Isoxyl) suspended in water, in oil and in its combinations with other so-called secondary tuberculostatics in experimental tuberculosis of mice, rabbits and guinea pigs].
    Fukuhara Y
    Jpn J Tuberc; 1967 Jul; 14(1):12-30. PubMed ID: 5300096
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of administration of more tuberculostatics on experimental tuberculosis].
    Durisić M; Drndarski K; Leposavić V
    Glas Srp Akad Nauka Med; 1969; (22):125-36. PubMed ID: 5202709
    [No Abstract]   [Full Text] [Related]  

  • 31. [Preclinical evaluation of alboverticillin, triculamine, and o-carbamyl-d-serine as a new antituberculous antibiotic].
    Kanai K; Koseki Y; Nakamura R; Okamoto S; Murohashi T
    Kekkaku; 1967 Jan; 42(1):37-42. PubMed ID: 6036570
    [No Abstract]   [Full Text] [Related]  

  • 32. [Relations between the indices of cellular immunity during chemotherapy of experimental tuberculosis].
    Gavrilenko AF; Stasiuk IM; Sibirnaia RI; Beliakova OI
    Probl Tuberk; 1983 Sep; (9):61-3. PubMed ID: 6647448
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of isoniazid derivatives synthesized using carbohydrate-type monomeric matrices as a base in experimental tuberculosis].
    Priĭmak AA; Suvorova VI; Sokolova GB; Braude VI; Antipov IuP
    Probl Tuberk; 1983 Jul; (7):55-8. PubMed ID: 6634678
    [No Abstract]   [Full Text] [Related]  

  • 34. [Oxidative metabolism changes in respiratory tract cells of guinea pigs during natural development of experimental tuberculosis and under specific chemotherapy].
    Kaminskaia GO; Abdullaev RIu
    Probl Tuberk; 1996; (2):33-6. PubMed ID: 8657693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanotechnology based drug delivery system(s) for the management of tuberculosis.
    Pandey R; Khuller GK
    Indian J Exp Biol; 2006 May; 44(5):357-66. PubMed ID: 16708887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on pyrazine derivatives. Part XIII. synthesis and tuberculostatic activity of some 6-alkyl-amino- and 6-dialkylhydrazinopyrazine-2-carboxylic acids derivatives.
    Foks H; Janowiec M; Manowska W
    Pol J Pharmacol Pharm; 1978; 30(1):113-8. PubMed ID: 417305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Overview on preclinical research on tuberculosis chemotherapy in the past 100 years. (2) Experimental studies following clinical tests].
    Kanei T; Kondo E
    Kekkaku; 1983 Apr; 58(4):235-45. PubMed ID: 6632485
    [No Abstract]   [Full Text] [Related]  

  • 38. [Dynamics of the rosette formation indices in the experimental tuberculosis chemotherapy process].
    Sibirnaia RI
    Probl Tuberk; 1981 Jun; (6):54-7. PubMed ID: 7279911
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies of the therapeutical effects and intolerance levels of morphazinamide in pulmonary tuberculosis].
    Ruiz Benítez G; Bonilla C
    Rev Clin Esp; 1967 Apr; 105(1):28-37. PubMed ID: 5613422
    [No Abstract]   [Full Text] [Related]  

  • 40. [CLINICAL AND EXPERIMENTAL DATA ON THE USE OF MORPHAZINAMIDE IN TUBERCULAR INFECTION].
    BLASI A; BERTI R; MORI G
    G Ital Chemioter; 1963; 10():201-3. PubMed ID: 14079403
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.